Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: An analysis of the National Cancer Database

Canadian Journal of Urology

Volumn 20, Issue 5, 2013, Pages 6915-6921

  Canter, Daniel J ^a   Mallin, Katherine ^b   Uzzo, Robert G ^c   Egleston, Robert G Uzzo ^c   Simhan, Jay ^c   Walton, John ^c   Smaldone, Marc C ^c   Master, Viraj A ^a   Bratslavsky, Gennady ^d   Kutikov, Alexander ^c  

^a EMORY UNIVERSITY   (United States)

^b AMERICAN COLLEGE OF SURGEONS   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Adrenal mass; Adrenalectomy; Adrenocortical carcinoma; National cancer database; Tumor size

Indexed keywords

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADULT; AGED; ARTICLE; CANCER REGISTRY; COHORT ANALYSIS; FACTUAL DATABASE; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEER PROGRAM; SURVIVAL RATE; YOUNG ADULT;

EID: 84888143538     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1):10-29.
2. Schteingart DE, Doherty GM, Gauger PG et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 2005;12(3):667-680.
3. Paton BL, Novitsky YW, Zerey M et al. Outcomes of adrenal cortical carcinoma in the United States. Surgery 2006;140(6):914-920; discussion 9-20.
4. Henley DJ, van Heerden JA, Grant CS et al. Adrenal cortical carcinoma--a continuing challenge. Surgery 1983;94(6):926-931.
5. Kutikov A, Crispen PL, Uzzo RG. Pathophysiology, evaluation, and medical management of adrenal disorders. In Wein AJ, Kavoussi LR, Partin AW, Peters CA eds, Campbell-Walsh Urology, 10th edn. Chapt 57. Philadelphia Elsevier, 2011:1685-1736.
6. Roman S. Adrenocortical carcinoma. Curr Opin Oncol 2006;18(1): 36-42.
7. Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab 2009;23(2):273-289.
8. Young WF, Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007;356(6):601-610.
9. Kloos RT, Gross MD, Francis IR et al. Incidentally discovered adrenal masses. Endocr Rev 1995;16(4):460-484.
10. Young WF Jr. Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 2000;29(1):159-185, x.
11. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006;29(4):298-302.
12. Barry MK, van Heerden JA, Farley DR et al. Can adrenal incidentalomas be safely observed? World J Surg 1998;22(6):599-603; discussion 4.
13. Simhan J, Smaldone MC, Canter DJ et al. Trends in regionalization of adrenalectomy to higher volume surgical centers. J Urol 2012; 188(2):377-382.
14. Kutikov A, Mallin K, Canter D et al. Effects of increased crosssectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Database. J Urol 2011; 186(3):805-810.
15. Bilimoria KY, Shen WT, Elaraj D et al. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 2008;113(11):3130-3136.
16. Herrera MF, Grant CS, van Heerden JA et al. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991;110(6):1014-1021.
17. Bilimoria KY, Stewart AK, Winchester DP et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol 2008;15(3):683-690.
18. Harrell F Jr. Regression modeling strategies. New York: Springer; 2001.
19. Parkin DM, Hakulinen T. Analysis of Survival. In: Cancer Registration: Principles and Methods (IARC Scientific Publications No. 95). Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Lyon: International Agency for Research on Cancer; 1991.
20. SPSS Inc. Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.
21. Lughezzani G, Jeldres C, Isbarn H et al. Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis. J Urol 2009;182(4):1287-1293.
22. Simhan J, Canter D, Teper E et al. Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study. Urology 2012;79(2):e19-20.
23. Barzon L, Sonino N, Fallo F et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003;149(4):273-285.
24. Mantero F, Terzolo M, Arnaldi G et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000;85(2): 637-644.
25. Kazaure HS, Roman SA, Sosa JA. Adrenalectomy in older Americans has increased morbidity and mortality: an analysis of 6,416 patients. Ann Surg Oncol 2011;18(10):2714-2721.